The studies reported herein suggest that IGF-1R-targeted approaches create a milieu that stimulates tumour angiogenesis, thus accelerating cancer metastasis and promoting a tumour's adaptive–evasive response to the therapy. This evidence concerns the gene IGF1R and neoplasm.